Clough Capital Partners »

Akero Therapeutics shares owned by Clough Capital Partners

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Clough Capital Partners from 13F filings

Historical chart of Clough Capital Partners investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Clough Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Clough Capital Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.7M 72k 50.58

More positions owned by Clough Capital Partners

Amazon (AMZN)
Meta Platforms Cl A (META)
Carnival Corp Unit 99/99/9999 Call Option (CCL)
Alphabet Cap Stk Cl C (GOOG)
Boeing Company Call Option (BA)
General Dynamics Corporation (GD)
D.R. Horton (DHI)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Pulte (PHM)
Teledyne Technologies Incorporated (TDY)
Broadcom (AVGO)
Dell Technologies CL C (DELL)
Lockheed Martin Corporation (LMT)
Charles Schwab Corporation (SCHW)

View all positions for Clough Capital Partners

Top funds holding Akero Therapeutics

Henderson Group
General Atlantic
BlackRock
Rtw Investments
Wellington Management Company
Deep Track Capital
venBio Select Advisor
State Street Corporation
Bellevue Group
Point72 Asset Management
Alkeon Capital Management
Geode Capital Management
Alliancebernstein
Marshall Wace
Logos Global Management

View all funds holding Akero Therapeutics